Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 13, 2020

SELL
$3.77 - $11.0 $7,540 - $22,000
-2,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$3.0 - $16.43 $300 - $1,643
100 Added 5.26%
2,000 $21,000
Q2 2019

Aug 13, 2019

BUY
$12.81 - $25.67 $24,339 - $48,773
1,900 New
1,900 $0

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Mint Tower Capital Management B.V. Portfolio

Follow Mint Tower Capital Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mint Tower Capital Management B.V. with notifications on news.